RIGL Gross Profit Growth
Rigel Pharmaceuticals Inc · Gross Profit Growth
RIGL Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported3.16%period ending
RIGL TTM Gross Profit YoY % (15.77% → 3.16%)
Year-over-year change
High-resolution chart · PNG
RIGL gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 3.162% | |
| 53.7793% | |
| 70.9888% | |
| 86.4862% | |
| 103.6301% | |
| 62.2687% | |
| 46.3315% | |
| 9.4168% | |
| -2.8944% | |
| -11.6435% | |
| -7.3599% | |
| 47.1279% | |
| 43.0038% | |
| 51.0403% | |
| -20.0198% | |
| -40.2303% | |
| -39.4548% | |
| -36.7085% | |
| 37.5276% | |
| 39.6312% | |
| 33.7015% | |
| 30.8965% | |
| 84.5192% | |
| 29.6799% | |
| 64.5979% | |
| 78.8382% | |
| 77.0224% | |
| 597.4092% | |
| 310.241% | |
| 228.2672% | |
| 178.9278% | |
| 58.1811% | |
| 25.1614% | |
| -14.2698% | |
| 2.9677% | |
| 8.4725% | |
| -27.073% | |
| -15.383% | |
| -26.9172% | |
| -31.5741% | |
| 29.1072% | |
| 40.1971% | |
| 42.923% | |
| 50.6462% | |
| 31.27% | |
| 13.3334% | |
| 12.8077% | |
| 13.5724% | |
| 14.6388% | |
| -10.154% | |
| -80.8435% | |
| -321.7551% | |
| -1,284.8297% | |
| -1,168.4545% | |
| -893.6842% | |
| 85.0844% | |
| 112.6235% | |
| 268.6599% | |
| -195.6262% | |
| -197.8585% | |
| -181.3014% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| 3.5197% | |
| -42.2591% | |
| -62.029% | |
| -62.3577% | |
| -78.7488% | |
| -58.6665% | |
| 10.1449% | |
| 102.5475% | |
| 213.3293% | |
| 273.1493% | |
| 305.9516% | |
| 249.1654% | |
| 102.2304% | |
| 25.0592% | |
| -27.11% | |
| -57.1868% | |
| -54.6288% | |
| -49.4119% | |
| -50.2996% | |
| -29.9785% | |
| -21.19% | |
| -14.4793% | |
| 5.1855% | |
| 3.1761% | |
| 10.3093% | |
| 21.367% | |
| 10.768% | |
| 15.7664% |